ReviewFrontiers in endocrinology2026
The hypoxia-epigenetics-ncRNA axis in endometriosis: from molecular cascades to self-sustaining pathogenic circuits.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endometriosis is a debilitating chronic inflammatory disorder driven by extensive molecular reprogramming. Despite significant bench research into its pathogenesis, translating these molecular discoveries into clinical practices that improve patient outcomes remains a critical challenge. This comprehensive review bridges the gap between basic life sciences and clinical application by delineating the hypoxia-epigenetics-non-coding RNA (ncRNA) axis as the primary engine of endometriosis pathogenesis. We elucidate how microenvironmental stress, specifically hypoxia via HIF-1α stabilization, initiates a coordinated cascade of aberrant DNA methylation, post-translational histone modifications, and ncRNA dysregulation. We illustrate how these isolated molecular events converge into a highly integrated, self-sustaining pathogenic circuit that drives hallmark clinical phenotypes, including progesterone resistance, chronic inflammation, and tissue invasiveness. To overcome traditional disciplinary silos, we propose a four-stage dynamic progression model that maps the transition from acute epigenetic stress to chronic disease manifestation, offering a robust framework for clinical stratification. Disrupting this specific axis offers new avenues for non-hormonal precision therapeutics and the development of non-invasive diagnostic biomarkers to address significant unmet clinical needs in endometriosis management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.